Rita Balice-Gordon
Director/Board Member at COLLEGIUM PHARMACEUTICAL, INC.
Net worth: 2 M $ as of 2024-05-30
Rita Balice-Gordon active positions
| Companies | Position | Start | End |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Director/Board Member | 2020-09-23 | - |
| Independent Dir/Board Member | 2020-09-23 | - | |
Muna Therapeutics ApS
 Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Director/Board Member | 2020-04-30 | - |
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 2020-04-30 | - | |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Director/Board Member | 2021-05-11 | - |
Career history of Rita Balice-Gordon
Former positions of Rita Balice-Gordon
| Companies | Position | Start | End |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
| Perelman School of Medicine | Corporate Officer/Principal | - | - |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | - | - |
Training of Rita Balice-Gordon
| Northwestern University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Statistics
International
| United States | 8 |
| Denmark | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Muna Therapeutics ApS
Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Health Services |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
- Stock Market
- Insiders
- Rita Balice-Gordon
- Experience
